Johnson & Johnson
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | $21.89B | $22.52B | $22.47B |
| Cost of Revenue | $8.05B | $8.11B | $7.97B | $7.30B | $7.63B | $7.36B | $7.13B | $6.96B |
| Gross Profit | $17.26B | $15.96B | $16.60B | $16.69B | $16.12B | $14.54B | $15.39B | $15.51B |
| Gross Margin | 68.2% | 66.3% | 67.6% | 69.6% | 67.9% | 66.4% | 68.3% | 69.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $6.43B | $6.03B | $6.75B | $5.92B | $5.89B | $5.11B | $6.45B | $5.48B |
| Operating Income | $6.75B | $5.99B | $4.97B | $7.49B | $6.49B | $13.63B | $3.89B | $3.34B |
| Operating Margin | 26.7% | 24.9% | 20.2% | 31.2% | 27.3% | 62.3% | 17.3% | 14.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $6.75B | $5.99B | $4.97B | $7.49B | $6.49B | $13.63B | $3.89B | $3.34B |
| Income Tax Expense | $1.21B | $755.0M | $-150.0M | $2.34B | $954.0M | $2.63B | $456.0M | $644.0M |
| Net Income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | $11.00B | $3.43B | $2.69B |
| Net Margin | 21.9% | 21.8% | 20.8% | 21.5% | 23.3% | 50.2% | 15.2% | 12.0% |
| EPS (Basic) | $2.30 | $2.17 | $2.12 | $2.14 | $2.30 | $4.57 | $1.42 | $1.12 |
| EPS (Diluted) | $2.27 | $2.14 | $2.08 | $2.12 | $2.29 | $4.54 | $1.41 | $1.11 |
| Shares Outstanding (Basic) | 2.41B | 2.41B | 2.41B | 2.41B | 2.41B | 2.41B | 2.41B | 2.41B |
| Shares Outstanding (Diluted) | 2.44B | 2.45B | 2.43B | 2.43B | 2.42B | 2.42B | 2.43B | 2.43B |
| Dividends Per Share | $1.34 | $1.30 | $1.30 | $1.30 | $1.30 | $1.24 | $1.24 | $1.24 |